Mary Abraham

University in Western Australia

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (10)

Elizabeth Davis

University of Western Australia

AUSTRALIA

View details

Ella Zomer

MONASH UNIVERSITY

AUSTRALIA

View details

Jenny Downs

University of Western Australia

AUSTRALIA

View details

Geoffrey Ambler

Clinical Professor

University of Sydney

AUSTRALIA

View details

Neale Cohen

Baker Heart and Diabetes Institute

AUSTRALIA

View details

Timothy Jones

University of Western Australia

AUSTRALIA

View details

Sybil A. McAuley

AUSTRALIA

View details

Jennifer Halliday

Deakin University

AUSTRALIA

View details

Aveni Haynes

University of Western Australia

AUSTRALIA

View details

Steven Trawley

Senior Lecturer

Cairnmillar Institute

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mary Abraham

Research Interests

Explore related searches

Contact this professor

Articles (10)

Glycemic and Psychosocial Outcomes of Advanced Hybrid Closed-Loop Therapy in Youth With High HbA<sub>1c</sub>

Real-world glycaemic outcomes in children and young people on advanced hybrid closed-loop therapy

Results of an Australian trial of an automated insulin delivery (AID) system and other studies support likely benefit of AID use for many Australian adults with type 1 diabetes

Septo-optic dysplasia and gastroschisis: trends in birth prevalence and association with maternal age

Resting Energy Expenditure and Metabolic Features in Children With Septo-Optic Dysplasia

Improved Glycemic Outcomes With Diabetes Technology Use Independent of Socioeconomic Status in Youth With Type 1 Diabetes

Advances in Automated Insulin Delivery with the Medtronic 780G

Clinical outcomes with MiniMedTM 780G Advanced Hybrid Closed Loop Therapy in 2- to 6-year-old children with Type 1 diabetes.

Six months of hybrid closed-loop therapy improves diabetes-specific positive well-being, and reduces diabetes distress and fear of hypoglycemia

"i Think i Could Have Used It Better"

Collaborators (10)

Elizabeth Davis

Ella Zomer

Jenny Downs

Geoffrey Ambler

Neale Cohen

Timothy Jones

Sybil A. McAuley

Jennifer Halliday

Aveni Haynes

Steven Trawley

Make your next move.